APA (7th ed.) Citation

Li, G., Marchevsky, N. G., Macaulay, G., Aley, P., Baughan, H., Plested, E., . . . Pollard, A. J. (2025). Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6–17 years: Final results of a phase 2, single-blind, randomised controlled trial (COV006). Vaccine, 62, N.PAG. https://doi.org/10.1016/j.vaccine.2025.127597

Chicago Style (17th ed.) Citation

Li, Grace, et al. "Safety and Immunogenicity of the ChAdOx1 NCoV-19 (AZD1222) Vaccine in Children Aged 6–17 Years: Final Results of a Phase 2, Single-blind, Randomised Controlled Trial (COV006)." Vaccine 62 (2025): N.PAG. https://doi.org/10.1016/j.vaccine.2025.127597.

MLA (9th ed.) Citation

Li, Grace, et al. "Safety and Immunogenicity of the ChAdOx1 NCoV-19 (AZD1222) Vaccine in Children Aged 6–17 Years: Final Results of a Phase 2, Single-blind, Randomised Controlled Trial (COV006)." Vaccine, vol. 62, 2025, p. N.PAG, https://doi.org/10.1016/j.vaccine.2025.127597.